However, given evidence of over two dozen splice variants for GAS5, it is likely that discrete control over these mechanisms may be variant and cell type specific, suggesting that the inconsistent regulatory patterns seen between cancers may be a result of differential variant expression, and thus, their differential control over these pathways. This evidence concerns the gene GAS5 and cancer.